Skip to main content

Table 1 Treatment outcomes

From: Levosimendan in critically ill adults: a utilisation review

Variable

Mean

95% CI

CI Δd5 - d0

+1.34

0.4 to 2.2

PFR Δd5 - d0

+284

223 to 345

BE Δd5 - d0

+2.9

0.85 to 5

Lac Δd5 - d0

-1

-2 to 0.2

  1. d0, treatment commenced.
Back to article page

Critical Care

ISSN: 1364-8535